1994
DOI: 10.1016/0304-4165(94)90008-6
|View full text |Cite
|
Sign up to set email alerts
|

DNA cleavage by Cu(II)-desferal: identification of C1′-hydroxylation as the initial event for DNA damage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

1994
1994
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 33 publications
0
8
0
Order By: Relevance
“…The primary site of DNA cleavage is located at position 14 that resides within one of the putative stem structures of the 46-mer. The catalyst also promotes DNA cleavage within a region located apart from the main cleavage site (16), as might be expected for a deoxyribozyme that makes use of an oxidative cleavage mechanism (20). Details from the further characterization of class II deoxyribozyme function will be reported elsewhere (N.C., R. Baliga, D. M. Crothers, and R.R.B., unpublished data).…”
Section: Resultsmentioning
confidence: 95%
“…The primary site of DNA cleavage is located at position 14 that resides within one of the putative stem structures of the 46-mer. The catalyst also promotes DNA cleavage within a region located apart from the main cleavage site (16), as might be expected for a deoxyribozyme that makes use of an oxidative cleavage mechanism (20). Details from the further characterization of class II deoxyribozyme function will be reported elsewhere (N.C., R. Baliga, D. M. Crothers, and R.R.B., unpublished data).…”
Section: Resultsmentioning
confidence: 95%
“…Since this transcription factor is implicated in Ulnar‐Mammary syndrome,26 the discovery of metal‐binding activity in this protein will help to understand the role of metals in regulating the transcription activity that will eventually provide information about the cause of this genetic disorder. There is at least one report in which a copper complex of desferal, a drug used for clinical treatment of a genetic disorder, has been shown to cleave DNA 62. Desferal is a siderophore of microbial origin that is used in the treatment of thalassemia.…”
Section: Discussionmentioning
confidence: 99%
“…Class I self-cleaving deoxyribozymes require Cu 2+ and ascorbate to promote DNA cleavage, whereas class II DNAs require only the addition of Cu 2+ as a cofactor. Class II self-cleaning deoxyribozymes [50] appear to catalyze the cleavage at one particular internucleotide linkage by promoting the attack of a hydroxyl radical at the 4¢ carbon [51], thereby initiating a series of rearrangements [52] that lead to loss of a nucleotide base and chain cleavage ( fig. 3 a).…”
Section: Dna-cleaving Deoxyribozymesmentioning
confidence: 99%